Clinical Trial Update: Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial evaluating KLS-1 as a monotherapy for malignant neoplasms, including chronic lymphocytic leukemia and solid tumors; currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Solid Tumors

Drugs mentioned

• KLS-1

Snippet

Sponsor: Vector Vitale LLC | Conditions: CLL, Solid Tumor, Adult | Phase 1, Phase 2 | Status: RECRUITING